Correlation Between Crispr Therapeutics and Prime Medicine,
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Prime Medicine, Common, you can compare the effects of market volatilities on Crispr Therapeutics and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Prime Medicine,.
Diversification Opportunities for Crispr Therapeutics and Prime Medicine,
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Crispr and Prime is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Prime Medicine, go up and down completely randomly.
Pair Corralation between Crispr Therapeutics and Prime Medicine,
Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 0.79 times more return on investment than Prime Medicine,. However, Crispr Therapeutics AG is 1.27 times less risky than Prime Medicine,. It trades about -0.03 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.26 per unit of risk. If you would invest 4,971 in Crispr Therapeutics AG on August 27, 2024 and sell it today you would lose (183.00) from holding Crispr Therapeutics AG or give up 3.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Crispr Therapeutics AG vs. Prime Medicine, Common
Performance |
| Timeline |
| Crispr Therapeutics |
| Prime Medicine, Common |
Crispr Therapeutics and Prime Medicine, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crispr Therapeutics and Prime Medicine,
The main advantage of trading using opposite Crispr Therapeutics and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |